1887

Abstract

is a leading cause of nosocomial infections, causing a spectrum of diseases ranging from diarrhoea to pseudomembranous colitis triggered by a range of virulence factors including toxins A (TcdA) and B (TcdB). TcdA and TcdB are monoglucosyltransferases that irreversibly glycosylate small Rho GTPases, inhibiting their ability to interact with their effectors, guanine nucleotide exchange factors, and membrane partners, leading to disruption of downstream signalling pathways and cell death. In addition, TcdB targets the mitochondria, inducing the intrinsic apoptotic pathway resulting in TcdB-mediated apoptosis. Modulation of apoptosis is a common strategy used by infectious agents. Recently, we have shown that the enteropathogenic (EPEC) type III secretion system effector NleH has a broad-range anti-apoptotic activity. In this study we examined the effects of NleH on cells challenged with TcdB. During infection with wild-type EPEC, NleH inhibited TcdB-induced apoptosis at both low and high toxin concentrations. Transfected alone was sufficient to block TcdB-induced cell rounding, nuclear condensation, mitochondrial swelling and lysis, and activation of caspase-3. These results show that NleH acts via a global anti-apoptotic pathway.

Loading

Article metrics loading...

/content/journal/micro/10.1099/mic.0.037259-0
2010-06-01
2020-08-03
Loading full text...

Full text loading...

/deliver/fulltext/micro/156/6/1815.html?itemId=/content/journal/micro/10.1099/mic.0.037259-0&mimeType=html&fmt=ahah

References

  1. Bartlett J. G., Moon N., Chang T. W., Taylor N., Onderdonk A. B.. 1978; Role of Clostridium difficile in antibiotic-associated Pseudomembranous colitis. Gastroenterology75:778–782
    [Google Scholar]
  2. Budihardjo I., Oliver H., Lutter M., Luo X., Wang X.. 1999; Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol15:269–290
    [Google Scholar]
  3. Caron E., Crepin V. F., Simpson N., Knutton S., Garmendia J., Frankel G.. 2006; Subversion of actin dynamics by EPEC and EHEC. Curr Opin Microbiol9:40–45
    [Google Scholar]
  4. Chae H. J., Kim H. R., Xu C., Bailly-Maitre B., Krajewska M., Krajewski S., Banares S., Cui J., Digicaylioglu M.. other authors 2004; BI-1 regulates an apoptosis pathway linked to endoplasmic reticulum stress. Mol Cell15:355–366
    [Google Scholar]
  5. Chen H. D., Frankel G.. 2005; Enteropathogenic Escherichia coli: unravelling pathogenesis. FEMS Microbiol Rev29:83–98
    [Google Scholar]
  6. Crane J. K., Majumdar S., Pickhardt D. F. III. 1999; Host cell death due to enteropathogenic Escherichia coli has features of apoptosis. Infect Immun67:2575–2584
    [Google Scholar]
  7. Crane J. K., McNamara B. P., Donnenberg M. S.. 2001; Role of EspF in host cell death induced by enteropathogenic Escherichia coli. Cell Microbiol3:197–211
    [Google Scholar]
  8. Desagher S., Martinou J. C.. 2000; Mitochondria as the central control point of apoptosis. Trends Cell Biol10:369–377
    [Google Scholar]
  9. Frankel G., Phillips A. D., Rosenshine I., Dougan G., Kaper J. B., Knutton S.. 1998; Enteropathogenic and enterohaemorrhagic Escherichia coli: more subversive elements. Mol Microbiol30:911–921
    [Google Scholar]
  10. Gao X., Wan F., Mateo K., Callegari E., Wang D., Deng W., Puente J., Li F., Chaussee M. S.. other authors 2009; Bacterial effector binding to ribosomal protein s3 subverts NF-kappaB function. PLoS Pathog5:e1000708
    [Google Scholar]
  11. Garmendia J., Phillips A. D., Carlier M. F., Chong Y., Schüller S., Marches O., Dahan S., Oswald E., Shaw R. K.. other authors 2004; TccP is an enterohaemorrhagic Escherichia coli O157 : H7 type III effector protein that couples Tir to the actin-cytoskeleton. Cell Microbiol6:1167–1183
    [Google Scholar]
  12. Garmendia J., Frankel G., Crepin V. F.. 2005; Enteropathogenic and enterohemorrhagic Escherichia coli infections: translocation, translocation, translocation. Infect Immun73:2573–2585
    [Google Scholar]
  13. Genth H., Aktories K., Just I.. 1999; Monoglucosylation of RhoA at threonine 37 blocks cytosol-membrane cycling. J Biol Chem274:29050–29056
    [Google Scholar]
  14. Genth H., Dreger S. C., Huelsenbeck J., Just I.. 2008; Clostridium difficile toxins: more than mere inhibitors of Rho proteins. Int J Biochem Cell Biol40:592–597
    [Google Scholar]
  15. George W. L., Sutter V. L., Goldstein E. J., Ludwig S. L., Finegold S. M.. 1978; Aetiology of antimicrobial-agent-associated colitis. Lancet1:802–803
    [Google Scholar]
  16. Gross A., Pilcher K., Blachly-Dyson E., Basso E., Jockel J., Bassik M. C., Korsmeyer S. J., Forte M.. 2000; Biochemical and genetic analysis of the mitochondrial response of yeast to BAX and BCL-X(L. Mol Cell Biol20:3125–3136
    [Google Scholar]
  17. Hemrajani C., Berger C. N., Robinson K. S., Marches O., Mousnier A., Frankel G.. 2010; NleH effectors interact with Bax inhibitor-1 to block apoptosis during enteropathogenic Escherichia coli infection. Proc Natl Acad Sci U S A107:3129–3134
    [Google Scholar]
  18. Herrmann C., Ahmadian M. R., Hofmann F., Just I.. 1998; Functional consequences of monoglucosylation of Ha-Ras at effector domain amino acid threonine 35. J Biol Chem273:16134–16139
    [Google Scholar]
  19. Iguchi A., Thomson N. R., Ogura Y., Saunders D., Ooka T., Henderson I. R., Harris D., Asadulghani M., Kurokawa K.. other authors 2009; Complete genome sequence and comparative genome analysis of enteropathogenic Escherichia coli O127 : H6 strain E2348/69. J Bacteriol191:347–354
    [Google Scholar]
  20. Just I., Gerhard R.. 2004; Large clostridial cytotoxins. Rev Physiol Biochem Pharmacol152:23–47
    [Google Scholar]
  21. Just I., Selzer J., Wilm M., von Eichel-Streiber C., Mann M., Aktories K.. 1995; Glucosylation of Rho proteins by Clostridium difficile toxin B. Nature375:500–503
    [Google Scholar]
  22. Kato H., Kato N., Watanabe K., Iwai N., Nakamura H., Yamamoto T., Suzuki K., Kim S. M., Chong Y., Wasito E. B.. 1998; Identification of toxin A-negative, toxin B-positive Clostridium difficile by PCR. J Clin Microbiol36:2178–2182
    [Google Scholar]
  23. Knutton S., Lloyd D. R., McNeish A. S.. 1987; Adhesion of enteropathogenic Escherichia coli to human intestinal enterocytes and cultured human intestinal mucosa. Infect Immun55:69–77
    [Google Scholar]
  24. Kroemer G., Reed J. C.. 2000; Mitochondrial control of cell death. Nat Med6:513–519
    [Google Scholar]
  25. Kuijper E. J., de Weerdt J., Kato H., Kato N., van Dam A. P., van der Vorm E. R., Weel J., van Rheenen C., Dankert J.. 2001; Nosocomial outbreak of Clostridium difficile-associated diarrhoea due to a clindamycin-resistant enterotoxin A-negative strain. Eur J Clin Microbiol Infect Dis20:528–534
    [Google Scholar]
  26. Kyne L., Hamel M. B., Polavaram R., Kelly C. P.. 2002; Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis34:346–353
    [Google Scholar]
  27. Le S. S., Loucks F. A., Udo H., Richardson-Burns S., Phelps R. A., Bouchard R. J., Barth H., Aktories K., Tyler K. L.. other authors 2005; Inhibition of Rac GTPase triggers a c-Jun- and Bim-dependent mitochondrial apoptotic cascade in cerebellar granule neurons. J Neurochem94:1025–1039
    [Google Scholar]
  28. Levine M. M., Berquist E. J., Nalin D. R., Waterman D. H., Hornick R. B., Young C. R., Stoman S., Rowe B.. 1978; Escherichia coli that cause diarrhoea but do not produce heat-labile or heat-stable enterotoxins and are non-invasive. Lancet1:1119–1122
    [Google Scholar]
  29. Limaye A. P., Turgeon D. K., Cookson B. T., Fritsche T. R.. 2000; Pseudomembranous colitis caused by a toxin A(−) B(+) strain of Clostridium difficile. J Clin Microbiol38:1696–1697
    [Google Scholar]
  30. Lyras D., O'Connor J. R., Howarth P. M., Sambol S. P., Carter G. P., Phumoonna T., Poon R., Adams V., Vedantam G.. other authors 2009; Toxin B is essential for virulence of Clostridium difficile. Nature458:1176–1179
    [Google Scholar]
  31. Mani N., Lyras D., Barroso L., Howarth P., Wilkins T., Rood J. I., Sonenshein A. L., Dupuy B.. 2002; Environmental response and autoregulation of Clostridium difficile TxeR, a sigma factor for toxin gene expression. J Bacteriol184:5971–5978
    [Google Scholar]
  32. Matamouros S., England P., Dupuy B.. 2007; Clostridium difficile toxin expression is inhibited by the novel regulator TcdC. Mol Microbiol64:1274–1288
    [Google Scholar]
  33. Matarrese P., Gambardella L., Cassone A., Vella S., Cauda R., Malorni W.. 2003; Mitochondrial membrane hyperpolarization hijacks activated T lymphocytes toward the apoptotic-prone phenotype: homeostatic mechanisms of HIV protease inhibitors. J Immunol170:6006–6015
    [Google Scholar]
  34. Matarrese P., Falzano L., Fabbri A., Gambardella L., Frank C., Geny B., Popoff M. R., Malorni W., Fiorentini C.. 2007; Clostridium difficile toxin B causes apoptosis in epithelial cells by thrilling mitochondria. Involvement of ATP-sensitive mitochondrial potassium channels. J Biol Chem282:9029–9041
    [Google Scholar]
  35. McNamara B. P., Koutsouris A., O'Connell C. B., Nougayrede J. P., Donnenberg M. S., Hecht G.. 2001; Translocated EspF protein from enteropathogenic Escherichia coli disrupts host intestinal barrier function. J Clin Invest107:621–629
    [Google Scholar]
  36. Nataro J. P., Kaper J. B.. 1998; Diarrheagenic Escherichia coli. Clin Microbiol Rev11:142–201
    [Google Scholar]
  37. Nougayrede J. P., Foster G. H., Donnenberg M. S.. 2007; Enteropathogenic Escherichia coli effector EspF interacts with host protein Abcf2. Cell Microbiol9:680–693
    [Google Scholar]
  38. Reineke J., Tenzer S., Rupnik M., Koschinski A., Hasselmayer O., Schrattenholz A., Schild H., von Eichel-Streiber C.. 2007; Autocatalytic cleavage of Clostridium difficile toxin B. Nature446:415–419
    [Google Scholar]
  39. Rupnik M., Wilcox M. H., Gerding D. N.. 2009; Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol7:526–536
    [Google Scholar]
  40. Schlosser-Silverman E., Elgrably-Weiss M., Rosenshine I., Kohen R., Altuvia S.. 2000; Characterization of Escherichia coli DNA lesions generated within J774 macrophages. J Bacteriol182:5225–5230
    [Google Scholar]
  41. Sehr P., Joseph G., Genth H., Just I., Pick E., Aktories K.. 1998; Glucosylation and ADP ribosylation of rho proteins: effects on nucleotide binding, GTPase activity, and effector coupling. Biochemistry37:5296–5304
    [Google Scholar]
  42. Tobe T., Beatson S. A., Taniguchi H., Abe H., Bailey C. M., Fivian A., Younis R., Matthews S., Marches O.. other authors 2006; An extensive repertoire of type III secretion effectors in Escherichia coli O157 and the role of lambdoid phages in their dissemination. Proc Natl Acad Sci U S A103:14941–14946
    [Google Scholar]
  43. Voth D. E., Ballard J. D.. 2005; Clostridium difficile toxins: mechanism of action and role in disease. Clin Microbiol Rev18:247–263
    [Google Scholar]
  44. Xu Q., Reed J. C.. 1998; Bax inhibitor-1, a mammalian apoptosis suppressor identified by functional screening in yeast. Mol Cell1:337–346
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/micro/10.1099/mic.0.037259-0
Loading
/content/journal/micro/10.1099/mic.0.037259-0
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error